skip to main content

Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung Cancer

HERBST, Roy S ; O'NEILL, Vincent J ; FEHRENBACHER, Louis ; BELANI, Chandra P ; BONOMI, Philip D ; HART, Lowell ; MELNYK, Ostap ; RAMIES, David ; MING LIN ; SANDLER, Alan

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4743-4750 [Revista revisada por pares]

Baltimore, MD: American Society of Clinical Oncology

Sin texto completo

Citas Citado por

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora